References

2. Bassett LW, Gold RH, Kimme-Smith C. History of the technical development of mammography. In: Haus AG, Yaffe MJ, eds. Syllabus: a categorical course in physics: technical aspects of breast imaging. Chicago: Radiological Society of North America, 1993:9.

3. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971;215:1777.

4. Baker L. Breast Cancer Detection Demonstration Project: five year summary report. CA Cancer J Clin 1982;32:196.

5. Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project . CA Cancer J Clin 1997;47:134.

6. Hurley SF, Kaldor JM. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 1992;14:101.

7. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829.

8. Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995;75:2507.

9. Tabar L, Duffy SW, Chen FM. Re: Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials [Letter; comment]. J Natl Cancer Inst 1996;88:52.

10. Tabar L, Chen HH, Fagerberg G, Duffy SW, Smith TC. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997;22:43.

11. Calder K. Access to screening mammography: patient concerns about insurance. Women's Health Issues 1992;2:189.

12. Health Care Financing Administration. Medicare covers mammograms, 1997. Available at: http://www.hcfa.gov/news/pr1997/ncireq.htm.

13. American Cancer Society. Survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 1990;40:77.

14. American Cancer Society. Cancer risk report: prevention and control, 1997. Atlanta: American Cancer Society, 1998.

15. Czaja R, McFall SL, Warnecke RB, Ford L, Kaluzny AD. Preferences of community physicians for cancer screening guidelines. Ann Intern Med 1994;120:602.

16. Young J, Ward J, Sladden M. Do the beliefs of Australian general practitioners about the effectiveness of cancer screening accord with the evidence? J Med Screen 1998;5:67.

17. Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates . J Natl Cancer Inst 1996;88:1571.

18. Brinton LA, Bernstein L, Colditz GA. Summary of the workshop: workshop on physical activity and breast cancer, November 13-14, 1997. Cancer 1998;83:595.

19. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk . JAMA 1997; 278:1407.

20. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study . J Natl Cancer Inst 1998;90:137.

21. Wilson JMG, Junger G. Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization, 1968.

22. Morrison A. Screening in chronic disease. New York: Oxford University Press, 1992.

23. Smith RA. Screening fundamentals. Monogr Natl Cancer Inst 1997;22:15.

24. Eddy D. ACS report on the cancer-related health checkup . CA Cancer J Clin 1980;30:193.

25. Healy BP. Screening mammography for women in their forties: the panel of Babel. J Women's Health 1997;6:1.

26. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development conference statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst 1997;89:1015.

27. Welch HG, Fisher ES. Diagnostic testing following screening mammography in the elderly. J Natl Cancer Inst 1998;90:1389.

28. Smith-Bindman R, Kerlikowske K. Is there a downside to elderly women undergoing screening mammography? J Natl Cancer Inst 1998;90:1322.

29. Organizing committee and collaborators. Breast cancer screening with mammography in women aged 40-49 years - report of the organizing committee and collaborators, Falun meeting, Falun, Sweden (March 2l-22, 1996) . Cancer 1996;68:693.

30. Rimer BK. Putting the "informed" in informed consent about mammography [Editorial; comment]. J Natl Cancer Inst 1995;87:703.

31. Harris RP, Fletcher SW, Gonzalez JJ, et al. Mammography and age: Are we targeting the wrong women? A community survey of women and physicians. Cancer 1991;67:2010.

32. Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening . N Engl J Med 1997;336:1180.

33. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast . JAMA 1996;275:913.

34. Sox RC. Benefit and harm associated with screening for breast cancer [Editorial; comment]. N Engl J Med 1998;338:1145.

35. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations . N Engl J Med 1998;338:1089.

36. Sickles EA. Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modem mammography. J Natl Cancer Inst Monogr 1997;22:99.

37. Linver M. Meet high expectations for mammography with high-quality services. Diagn Imaging 1998;20:89.

38. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998 [Published erratum appears in CA Cancer J Clin 1998;48:192]. CA Cancer J Clin 1998;48:6.

39. Ries L, Kosary C, Hankey B, et al. SEER cancer statistics review, 1973-1995. Bethesda, MD: National Cancer Institute, 1998.

40. Duffy SW, Chen HH, Tabar L, Day NE. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med 1995;14:1531.

41. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 1996;66:413.

42. Tabar L, Fagerberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987;55:547.

43. Ries L, Henson D, Harras A. Survival from breast cancer according to tumor size and nodal status. Surg Oncol Clin N Am 1994;3:35.

44. Miller AB. Fundamentals of screening. In: Miller AB, ed. Screening for cancer. Orlando: Academic, 1985:3.

45. Kopans DB. An overview of the breast cancer screening controversy. J Natl Cancer Inst Monogr 1997;22:1.

46. Sickles EA, Kopans DB. Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst 1993;85:1621.

47. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349.

48. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the health insurance plan project and its sequelae. Baltimore: Johns Hopkins Press, 1988.

49. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107.

50. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943.

51. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmö mammographic screening program. J Natl Cancer Inst Monogr 1997;22:63.

52. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49.

53. Bjurstam N, Bjomeld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization . Cancer 1997;80:2091.

54. Roberts MM, Alexander FE, Anderson TJ, et al. The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer 1984;50:1.

55. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994;70:542.

56. Miller AB, Baines CJ, To T, Wall C. Canadian national breast screening study. 1. Breast cancer detection and death rates among women aged 40 to 49 years [Published erratum appears in Can Med Assoc J 1993;148:718;]. Can Med Assoc J 1992;147:1459.

57. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. Monogr Natl Cancer Inst 1997;22:37.

58. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol 1993;161:755.

59. Mettlin CJ, Smart CR. The Canadian National Breast Screening Study. An appraisal and implications for early detection policy. Cancer 1993;72:1461.

60. Burhenne LJ, Burhenne HJ. The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol 1993;161:761.

61. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995;75:997.

62. Bailar JC, MacMahon B. Randomization in the Canadian National Breast Cancer Screening Study. Report of a review team appointed by the National Cancer Institute of Canada. Can Med Assoc J 1997;156:213.

63. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. 2. Breast cancer detection and death rates among women aged 50 to 59 years [Published erratum appears in Can Med Assoc J 1993;148:7181;]. Can Med Assoc J 1992;147:1477.

64. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer . J Natl Cancer Inst 1993;85:1644.

65. Kopans DB. Screening for breast cancer and mortality reduction among women 40-49 years of age. Cancer 1994;74:311.

66. Wald N, Chamberlain J, Hackshaw A. Report of the European Society of Mastology Breast Cancer Screening Committee. Breast 1993;2:209.

67. Eckhardt S, Badellino F, Murphy GP. UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993. Int J Cancer 1994;56:1.

68. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women [Published errata appear in Online J Curr Clin Trials March 5, 1993; doc 34 and March 31, 1994; doc 121;]. Online J Curr Clin Trials 1993; doc 32. Accessed 25 February 1993.

69. Elwood K, Cox B, Richardson A. The effectiveness of breast cancer screening by mammography in younger women: correction [Letter]. Online J Curr Clin Trials 1994; doc 121. Accessed 25 February 1993.

70. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials [Published erratum appears in Cancer 1995;75:11]. Cancer 1995;75:1619.

71. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis . JAMA 1995;273:1,49.

72. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22:87.

73. Kopans DB. Mammography screening and the controversy concerning women aged 40 to 49. Radiol Clin North Am 1995;33:1273.

74. Foffest AP, Alexander FE. A question that will not go away: at what age should mammographic screening begin? [Editorial; comment]. J Natl Cancer Inst 1995;87:1195.

75. Prorok PC, Hankey BF, Bundy BN. Concepts and problems in the evaluation of screening programs. J Chron Dis 1981;34:159.

76. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials . J Natl Cancer Inst 1995;87:1217.

77. Duffy SW, Day NE, Tabar L, Chen RH, Smith TC. Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr 1997;22:93.

78. Tabar L, Duffy SW, Burhenne LW. New Swedish breast cancer detection results for women aged 40-49. Cancer 1993;72:1437.

79. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187.

80. Bassett LW, Hendrick RE, Bassford TI, et al. Quality determinants of mammography. Clinical practice guidelines, No. 13. Publication No. 95-00632. Rockville, MD: Agency for Health Care Policy and Research Public Health Service, US Department of Health and Human Services, 1994.

81. Bird RE. Analysis of cancers missed at screening mammography. Radiology 1989;171:87.

82. Burhenne LW, Hislop TG, Burhenne H. Xeromammographic diagnosis of carcinoma of the breast in office practice. Surg Gynecol Obst 1987;164:452.

83. Reinig JW, Strait CJ. Professional mammographic quality assessment program for a community hospital. Radiology 1991;180:393.

84. Linver MN, Paster SB, Rosenberg RD, Key CR, Stidley CA, King WV. Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases [Published erratum appears in Radiology 1992;184:878]. Radiology 1992;184:39.

85. Sickles EA, Oniinsky SH, Sollitto RA, Galvin BB, Monticciolo DL. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 1990;175:323.

86. Sickles EA. Quality assurance: how to audit your own mammography practice. Radiol Clin North Am 1992;30:265.

87. American College of Radiology. Illustrated breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology, 1998.

88. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984;40:1.

89. Baines CJ, Miller AB, Wall C, et al. Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers. Radiology 1986;160:295.

90. Lynde JL. A community program of low-cost screening mammography: the results of 21,141 consecutive examinations. South Med J 1993;86:338.

91. Robertson CL. A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 1993;187:75.

92. Mosenson D. Audit of mammography in a community setting. Am J Surg 1992;163:544.

93. Linver MN, Paster SB. Mammography outcomes in a practice setting by age: prognostic factors, sensitivity, and positive biopsy rate. J Natl Cancer Inst Monogr 1997;22:113.

94. Duffy SW, Chen HH, Tabar L, Fagerberg G, Paci E. Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49. Int J Epidemiol 1996;25:1139.

95. May D, Lee N, Nadel M, et al. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. Am J Radiol 1998;170:97.

96. Rosenquist CJ, Lindfors KK. Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness. Cancer 1998;82:2235.

97. Leitch AM, Dodd GD, Costanza M, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997;47:150.

98. National Cancer Institute. Statement from the National Cancer Institute on the National Cancer Advisory Board recommendations on mammography. Bethesda, MD: National Cancer Institute, 1997.

99. U.S. Preventive Services Task Force. Guide to clinical preventive services. Baltimore: Williams & Wilkins, 1996.

100. U.S. Senate Special Committee on Aging. Aging America. Washington, DC: U.S. Department of Health and Human Services, 1991.

101. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39:2772.

102. Smart CR. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994;74:296.

103. American Cancer Society. Cancer risk report: prevention and control, 1999. Atlanta: American Cancer Society, 1999.

104. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 11. BRCA1 and BRCA2. Cancer Genetics Studies Consortium . JAMA 1997;277:997.

105. Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 1998;16:3105.

106. Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst 1998;90:1431.

107. National Cancer Institute. Breast cancer risk assessment tool 1999. Bethesda, MD: National Cancer Institute, 1998.

108. Solin L, Schwartz G, Feig S, Shaber G, Patchefsky A. Risk factors as criteria for inclusion in breast cancer screening programs. In: Ames F, Blumenschein G, Montague E, eds. Current controversies in breast cancer. Austin, TX: University of Texas Press, 1984.

109. Alexander F, Roberts K, Huggins A. Risk factors for breast cancer with applications to selection for the prevalence screen. J Epidemiol Community Health 1987;41:101.

110. Madigan W, Ziegler RG, Benichou J, Byme C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681.

111. Conway BJ, McCrohan JL, Rueter FG, Suleiman OH. Mammography in the eighties. Radiology 1990;177:335.

112. McLelland R, Hendrick RE, Zinniger MD, Wilcox PA. The American College of Radiology mammography accreditation program . AJR Am J Roentgenol 1991;157:473.

113. Fintor L, Alciati NM, Fischer R. Legislative and regulatory mandates for mammography quality assurance. J Public Health Policy 1995;16:81.

114. Hendrick RE, Smith RA, Wilcox PA. ACR accreditation and legislative issues in mammography. In: Haus AG, Yaffee MJ, eds. Syllabus: a categorical course in physics: technical aspects of breast imaging. Chicago: Radiological Society of North America, 1993:137.

115. Cardenosa G, Eklund GW. Rate of compliance with recommendations for additional mammographic views and biopsies. Radiology 1991;181:359.

116. Monsees B, Destouet JM, Evens RG. The self-referred mammography patient: a new responsibility for radiologists. Radiology 1988;166:69.

117. Smith RA, Osuch JR, Linver MN. A national breast cancer database. Radiol Clin North Am 1995;33:1247.

118. Sickles EA. Management of probably benign lesions of the breast. Radiology 1996;193:582.

119. Elmore JG, WelIs CF, Carol MPH, et al. Variability in radiologists' interpretation of mammograms. N Engl J Med 1993;331:99.

120. D'Orsi CJ, Swets JA. Letter to the editor. N Engl J Med 1995; 132:1172.

121. Van Gils CH, Otten JD, Verbeek AL, Hendricks JH. Mammographic breast density and risk of breast cancer: masking bias or causability? Eur J Epidemiol 1998;14:315.

122. Qian W, Clarke L. Digital mammography: computer-assisted diagnosis method for mass detection with multi-orientation and multi-resolution wavelet transforms. Acad Radiol 1997;4:724.

123. Kalman BL, Reinus WR, Kwasny SC, Laine A, Kotner L. Prescreening entire mammograms for masses with artificial neural networks: preliminary results. Acad Radiol 1997;4:405.

124. Lewin JM, Hendrick RE, D'Orsi CJ, Moss LJ, Sisney GE, Karellas A. Clinical evaluation of a full-field digital mammography prototype for cancer detection in a screening setting - work in progress. Presented at the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 1998.

125. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986;10:199.

126. Cosgrove DO, Kedar RP, Bamber JC, et al. Breast diseases: color Doppler US in differential diagnosis . Radiology 1993;189:99.

127. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931.

128. -Strich G, Hagan PL, Gerber KH, Slutsky RA. Tissue distribution andmagnetic resonance spin lattice relaxation effects of gadolinium-DTPA. Radiology 1985;154:723.

129. Brasch RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 1984;142:625.

130. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995;196:593.